{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:55:59Z","timestamp":1788393359027,"version":"build-2803163510"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T00:00:00Z","timestamp":1536278400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02030","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T04:29:22Z","timestamp":1536294562000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":80,"title":["Radiation and Local Anti-CD40 Generate an Effective in situ Vaccine in Preclinical Models of Pancreatic Cancer"],"prefix":"10.3389","volume":"9","author":[{"given":"Sayeda","family":"Yasmin-Karim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Bruck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijumon","family":"Kunjachan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Grabow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie K.","family":"Dougan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfred","family":"Ngwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1002\/jcb.26005","article-title":"Targeting immunotherapy to the tumor microenvironment","volume":"118","author":"Dougan","year":"2017","journal-title":"J Cell Biochem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1158\/2326-6066.CIR-13-0022","article-title":"Getting personal with neoantigen-based therapeutic cancer vaccines","volume":"1","author":"Hacohen","year":"2013","journal-title":"Cancer Immunol Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/bs.ai.2015.12.001","article-title":"Advances in therapeutic cancer vaccines","volume":"130","author":"Wong","year":"2016","journal-title":"Adv Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"eaan4488","DOI":"10.1126\/scitranslmed.aan4488","article-title":"Eradication of spontaneous malignancy by local immunotherapy","volume":"10","author":"Sagiv-Barfi","year":"2018","journal-title":"Sci Transl Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat Rev Drug Discov."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1200\/JCO.2017.73.7379.","article-title":"Randomized, open-label phase II study evaluating the efficacy and safety of talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone in patients with advanced, unresectable melanoma","volume":"36","author":"Chesney","year":"2017","journal-title":"J Clin Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.1158\/1078-0432.CCR-12-0984","article-title":"Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancer","volume":"18","author":"Dewan","year":"2012","journal-title":"Clin Cancer Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.18632\/oncotarget.3081","article-title":"Radiotherapy combined with TLR7\/8 activation induces strong immune responses against gastrointestinal tumors","volume":"6","author":"Scholch","year":"2015","journal-title":"Oncotarget"},{"key":"B13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1158\/0008-5472.CAN-14-3619","article-title":"Radiotherapy combined with novel STING-targeting oligonucleotides results in regression of established tumors","volume":"76","author":"Baird","year":"2016","journal-title":"Cancer Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1056\/NEJMoa1112824","article-title":"Immunologic correlates of the abscopal effect in a patient with melanoma","volume":"366","author":"Postow","year":"2012","journal-title":"N Engl J Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1046028","DOI":"10.1080\/2162402X.2015.1046028","article-title":"A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab","volume":"4","author":"Chandra","year":"2015","journal-title":"Oncoimmunology"},{"key":"B17","first-page":"219","article-title":"Immune effects of targeted radiation therapy for cancer","volume":"19","author":"Sridharan","year":"2015","journal-title":"Discov Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint","year":"2015","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1158\/2326-6066.CIR-17-0134","article-title":"Radiotherapy and CTLA-4 blockade shape the TCR repertoire of tumor-infiltrating T Cells","volume":"6","author":"Rudqvist","year":"2018","journal-title":"Cancer Immunol Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1158\/1078-0432.CCR-16-0870","article-title":"Tumor-Derived CCL2 Mediates resistance to radiotherapy in pancreatic ductal adenocarcinoma","volume":"23","author":"Kalbasi","year":"2017","journal-title":"Clin Cancer Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1126\/science.1198443","article-title":"CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans","volume":"331","author":"Beatty","year":"2011","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","first-page":"6286","DOI":"10.1158\/1078-0432.CCR-13-1320","article-title":"A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma","volume":"19","author":"Beatty","year":"2013","journal-title":"Clin Cancer Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1016\/j.celrep.2016.05.058","article-title":"CD40 stimulation obviates innate sensors and drives t cell immunity in cancer","volume":"15","author":"Byrne","year":"2016","journal-title":"Cell Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1158\/2159-8290.CD-15-1032","article-title":"IFN gamma and CCL2 cooperate to redirect tumor-infiltrating monocytes to degrade fibrosis and enhance chemotherapy efficacy in pancreatic carcinoma","volume":"6","author":"Long","year":"2016","journal-title":"Cancer Discov."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1158\/0008-5472.CAN-17-3821","article-title":"Radiotherapy and CD40 activation separately augment immunity to checkpoint blockade in cancer","volume":"78","author":"Rech","year":"2018","journal-title":"Cancer Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00262-018-2115-2","article-title":"Combined sublethal irradiation and agonist anti-CD40 enhance donor T cell accumulation and control of autochthonous murine pancreatic tumors","volume":"67","author":"Ward-Kavanagh","year":"2018","journal-title":"Cancer Immunol Immunother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/PPO.0000000000000288","article-title":"The pancreatic cancer microenvironment","volume":"23","author":"Dougan","year":"2017","journal-title":"Cancer J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ccr.2012.04.025","article-title":"Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer","volume":"21","author":"Bayne","year":"2012","journal-title":"Cancer Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1172\/JCI63606","article-title":"Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans","volume":"122","author":"Ochi","year":"2012","journal-title":"J Clin Invest."},{"key":"B30","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccr.2012.04.024","article-title":"Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia","volume":"21","author":"Pylayeva-Gupta","year":"2012","journal-title":"Cancer Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature19823","article-title":"A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns","volume":"538","author":"Notta","year":"2016","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tcb.2017.08.007","article-title":"cGAS conducts micronuclei DNA surveillance","volume":"27","author":"de","year":"2017","journal-title":"Trends Cell Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature25492","article-title":"TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1158\/2326-6066.CIR-13-0207","article-title":"TGFbeta inhibition prior to hypofractionated radiation enhances efficacy in preclinical models","volume":"2","author":"Young","year":"2014","journal-title":"Cancer Immunol Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1158\/0008-5472.CAN-14-3511","article-title":"TGFbeta is a master regulator of radiation therapy-induced antitumor immunity","volume":"75","author":"Vanpouille-Box","year":"2015","journal-title":"Cancer Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1074\/jbc.M110168200","article-title":"Restoration of transforming growth factor-beta signaling enhances radiosensitivity by altering the Bcl-2\/Bax ratio in the p53 mutant pancreatic cancer cell line MIA PaCa-2","volume":"277","author":"Ahmed","year":"2002","journal-title":"J Biol Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ccell.2018.03.008","article-title":"The immune revolution: a case for priming, not checkpoint","volume":"33","author":"Vonderheide","year":"2018","journal-title":"Cancer Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1053\/j.gastro.2015.04.010","article-title":"Exclusion of T cells from pancreatic carcinomas in mice is regulated by Ly6C F4\/80 extratumoral macrophages","volume":"149","author":"Beatty","year":"2015","journal-title":"Gastroenterology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1158\/2326-6066.CIR-17-0495","article-title":"Targeting cytokine therapy to the pancreatic tumor microenvironment using PD-L1-specific VHHs","volume":"6","author":"Dougan","year":"2018","journal-title":"Cancer Immunol Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"6754","DOI":"10.1158\/1078-0432.CCR-11-0544","article-title":"TGFbeta1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo","volume":"17","author":"Bouquet","year":"2011","journal-title":"Clin Cancer Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1084\/jem.190.3.355","article-title":"Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte\/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation","volume":"190","author":"van","year":"1999","journal-title":"J Exp Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/JCO.2014.57.4756","article-title":"Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: a systematic review and meta-analysis","volume":"33","author":"Teulings","year":"2015","journal-title":"J Clin Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"eaam6346","DOI":"10.1126\/sciimmunol.aam6346","article-title":"Resident memory T cells in the skin mediate durable immunity to melanoma","volume":"2","author":"Malik","year":"2017","journal-title":"Sci Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ctro.2017.12.004","article-title":"Combining radiotherapy and ipilimumab induces clinically relevant radiation-induced abscopal effects in metastatic melanoma patients: a systematic review","volume":"9","author":"Chicas-Sett","year":"2018","journal-title":"Clin Transl Radiat Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.canlet.2015.03.024","article-title":"Awakening the immune system with radiation: optimal dose and fractionation","volume":"368","author":"Gandhi","year":"2015","journal-title":"Cancer Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e0157164","DOI":"10.1371\/journal.pone.0157164","article-title":"Optimizing timing of immunotherapy improves control of tumors by hypofractionated radiation therapy","volume":"11","author":"Young","year":"2016","journal-title":"PLoS ONE"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1214790","DOI":"10.1080\/2162402X.2016.1214790","article-title":"Trial watch: immunotherapy plus radiation therapy for oncological indications","volume":"5","author":"Vacchelli","year":"2016","journal-title":"Oncoimmunology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","article-title":"Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody","volume":"15","author":"Dewan","year":"2009","journal-title":"Clin Cancer Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1158\/2326-6066.CIR-14-0196","article-title":"Stereotactic Radiation therapy augments antigen-specific PD-1-mediated antitumor immune responses via cross-presentation of tumor antigen","volume":"3","author":"Sharabi","year":"2015","journal-title":"Cancer Immunol Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1158\/2326-6066.CIR-15-0253","article-title":"Antitumor efficacy of radiation plus immunotherapy depends upon dendritic cell activation of effector CD8+ T Cells","volume":"4","author":"Dovedi","year":"2016","journal-title":"Cancer Immunol Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.radonc.2014.03.014","article-title":"Contextual regulation of pancreatic cancer stem cell phenotype and radioresistance by pancreatic stellate cells","volume":"111","author":"Al-Assar","year":"2014","journal-title":"Radiother Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"6981","DOI":"10.1158\/0008-5472.CAN-07-0491","article-title":"Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo","volume":"67","author":"Dennler","year":"2007","journal-title":"Cancer Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.1158\/0008-5472.CAN-13-1807","article-title":"Neutralizing murine TGFbetaR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis","volume":"74","author":"Ostapoff","year":"2014","journal-title":"Cancer Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.3389\/fimmu.2017.01547","article-title":"Checkpoint blockade toxicity and immune homeostasis in the gastrointestinal tract","volume":"8","author":"Dougan","year":"2017","journal-title":"Front Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1158\/2326-6066.CIR-13-0047","article-title":"Transnuclear TRP1-specific CD8 T cells with high or low affinity TCRs show equivalent antitumor activity","volume":"1","author":"Dougan","year":"2013","journal-title":"Cancer Immunol Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"345473","DOI":"10.1155\/2013\/345473","article-title":"Report of a case of radiation-induced new-onset vitiligo with collective review of cases in the literature of radiation-related vitiligo","volume":"2013","author":"Pavithran","year":"2013","journal-title":"Case Rep Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.lungcan.2017.04.019","article-title":"Vitiligo in a patient with lung adenocarcinoma treated with nivolumab: a case report","volume":"109","author":"Uenami","year":"2017","journal-title":"Lung Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"18508","DOI":"10.18632\/oncotarget.7610","article-title":"Transformation of the tumour microenvironment by a CD40 agonist antibody correlates with improved responses to PD-L1 blockade in a mouse orthotopic pancreatic tumour model","volume":"7","author":"Luheshi","year":"2016","journal-title":"Oncotarget"},{"key":"B60","doi-asserted-by":"publisher","first-page":"328","DOI":"10.7150\/thno.13624","article-title":"Imalytics preclinical: interactive analysis of biomedical volume data","volume":"6","author":"Gremse","year":"2016","journal-title":"Theranostics"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02030\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T04:29:24Z","timestamp":1536294564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02030\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,7]]},"references-count":60,"alternative-id":["10.3389\/fimmu.2018.02030"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02030","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,7]]},"article-number":"2030"}}